pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Rare genetic variant linked to much higher lung cancer risk in never-smokers

Sep 17, 2026·read at STAT ↗Positive

Researchers have discovered a very rare genetic variant that dramatically increases the odds of developing lung cancer among people who have never smoked. The study, published in Science, reports a roughly 25‑fold higher risk for carriers of the variant.

Analysis of a large dataset shows the variant is more prevalent in individuals from Southern Appalachia in the United States than elsewhere. Although the mutation is uncommon, its presence may explain a portion of lung‑cancer cases in never‑smokers.

The findings suggest that distinct genetic risk factors can drive tumor development in this population, which could influence future screening recommendations and therapeutic approaches. Experts caution that the variant likely accounts for only a small fraction of never‑smoker lung cancers, but it highlights the need for tailored research and clinical strategies.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Why do ‘never smokers’ get lung cancer? In some cases, rare genetic variant may be a factor”

read at STAT ↗
509 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.5AMICUS THERAPEUTICS, INC.2
drugs
FENTANYL-37FENTANYL-75fentanylfentanyl CRfentanyl ER
topics
Oncology11Pulmonology9NSCLC7Rare Disease5

related stories

  • Apr 27New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies projectSTAT
  • 5h agoPurer fentanyl won’t solve the U.S. overdose death crisis, study saysSTAT
  • Jul 28Anthony Fauci’s pandemic-era diary entriesSTAT
  • Apr 27STAT+: Zap in a cap: How one neurotech startup is using a hat to treat depressionSTAT
  • 1d agoSionna says good-bye to 46% of staffers, including execBioSpace